761
Views
29
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences

, , , , , , , & show all
Pages 882-888 | Received 10 Jun 2016, Accepted 24 Jul 2016, Published online: 21 Sep 2016

References

  • Iwamoto FM, DeAngelis LM, Abrey LE. Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology. 2006;66:1763–1765.
  • Tu PH, Giannini C, Judkins AR, et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol. 2005;23:5718–5727.
  • Kudrimoti JK, Gaikwad MJ, Puranik SC, et al. Primary dural non-Hodgkin’s lymphoma mimicking meningioma: a case report and review of literature. J Cancer Res Ther. 2015;11:648.
  • Chourmouzi D, Potsi S, Moumtzouoglou A, et al. Dural lesions mimicking meningiomas: a pictorial essay. World J Radiol. 2012;4:75–82.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
  • Tandon BPL, Gao J, Nelson B, et al. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol. 2011;24:1433–1443.
  • Miranda RN, Glantz LK, Myint MA, et al. Stage IE non Hodgkin's lymphoma involving the dura. Arch Pathol Lab Med. 1996;120:254–260.
  • Mneimneh WS, Ashraf MA, Li L, et al. Primary dural lymphoma: a novel concept of heterogeneous disease. Pathol Int. 2013;63:68–72.
  • Abdullah S, Morgensztern D, Rosado M, et al. Primary lymphoblastic B-cell lymphoma of the cranial dura mater: a case report and review of the literature. Leuk Lymphoma. 2009;46:1651–1657.
  • Puri DR, Tereffe W, Yahalom J. Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. Int J Radiat Oncol Biol Phys. 2008;71:1425–1435.
  • Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology. 2002;224:797–803.
  • Mabray MC CB, Villanueva-Meyer JE, Valles FE, et al. Performance of apparent diffusion coefficient values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms. AJR Am J Roentgenol. 2015;205: 1075–1085.
  • Toh CH CM, Wong AM, Wei KC, et al. Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging. AJNR. 2008;29:1630–1635.
  • Stadnik TW1 CC, Michotte A, Shabana WM, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR. 2001;22:969–976.
  • Filippi CG EM, Uluğ AM, Prowda JC, et al. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR. 2001;22:65–72.
  • Yahalom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92:11–31.
  • Bayraktar S, Bayraktar UD, Stefanovic A, et al. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol. 2011;152:72–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.